Beijing AnDing hospital affiliated to Capital Medical University
Welcome,         Profile    Billing    Logout  
 40 Trials 
72 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Qing
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Recruiting
3
368
Europe, US, RoW
SHR0302, Placebo
Reistone Biopharma Company Limited, Reistone Biopharma Company Limited
Ulcerative Colitis
10/24
03/25
FS-1502-III1-01, NCT05755048: FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Recruiting
3
314
RoW
Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Breast Cancer
07/25
01/26
NCT04649242 / 2020-003517-35: Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Recruiting
3
2100
Europe, Canada, Japan, US, RoW
Rimegepant/BHV3000, Matching placebo
Pfizer
Pediatric Migraine
01/29
01/29
NCT05133856: A Study of TAF in Combination With PEG-IFN and Hepalatide in Subjects With Chronic Hepatitis B

Not yet recruiting
2
30
RoW
hepalatide, L47, Pegylated Interferon, PegIFN-alpha-2a, TAF, Vemlidy, Placebo
Shanghai HEP Pharmaceatical Co., Ltd.
Hepatitis B, Chronic
12/23
06/24
NCT06289751: Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Recruiting
2
50
RoW
Cadonilimab, Cadonilimab Injection, AK104, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, Extrafascial hysterectomy, Radical hysterectomy, Cone biopsy
Tongji Hospital, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Women Hospital, School of Medicine, Zhejiang University, Southwest Hospital, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital
Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy, Extrafascial Hysterectomy
03/26
01/31
SPHIC-TR-PCa2021-01, NCT05106699: Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Recruiting
2
54
RoW
proton plus carbon ion radiation
Shanghai Proton and Heavy Ion Center
Prostate Cancer
05/25
05/26
NCT05938374: Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma

Recruiting
2
100
RoW
Fluzoparib, RT+Fluzoparib, Preoperative moderately fractionated radiotherapay, RT
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Jishuitan Hospital
Soft Tissue Sarcoma
04/26
12/26
NCT06285227: Study of CM313 in Healthy Subjects

Recruiting
1
51
RoW
CM313 injection
Keymed Biosciences Co.Ltd
Healthy
04/25
04/25
NCT06298266: To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

Not yet recruiting
1
15
RoW
infusion of GPRC5D-CD19 CAR T injection
Guangdong Second Provincial General Hospital
Relapsed or Refractory Multiple Myeloma
05/26
12/26
NCT06045585: JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

Recruiting
1
20
RoW
infusion of JY231 injection
Guangdong Second Provincial General Hospital
Relapsed or Refractory B-cell Lymphoma
08/25
12/25
NCT04969354: Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma

Recruiting
1
20
RoW
CAR-T cell immunotherapy
The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University
Immunotherapy
09/25
09/26
XYFY2021-KL172-02, NCT05354375: Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Recruiting
1
20
RoW
CAR-T cell immunotherapy
The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University
Immunotherapy
11/25
11/26
NCT02739659: Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Recruiting
N/A
73
RoW
carbon-ion radiotherapy
Shanghai Proton and Heavy Ion Center
Prostate Carcinoma
12/22
12/24
NCT05193331: Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye

Not yet recruiting
N/A
70
RoW
3% Diquafosol tetrasodium, Diquas
He Eye Hospital, Santen Pharmaceutical(China) Co.,LTD
Diabetic Eye Problems
08/23
11/23
NCT04980144: Diquafosol Ophthalmic Solution for Dry Eye Symptoms

Not yet recruiting
N/A
101
RoW
3% Diquafosol tetrasodium, Diquas, 0.1% hyaluronate, Artificial tears
He Eye Hospital
Diabetic Eye Problems
08/23
11/23
NCT06158984: Managing Dry Eye in Patients Using Glaucoma Drops

Completed
N/A
60
RoW
IPL, Intense pulsed light
He Eye Hospital
Dry Eye
12/23
12/23
NCT06158997: Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease

Not yet recruiting
N/A
60
RoW
EyePeace, Eye massager, Heated Eye Mask, HEM
He Eye Hospital
Evaporative Dry Eye
02/24
04/24
NCT05330923: Effect of NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

Recruiting
N/A
200
RoW
Peking Union Medical College Hospital, Wuxi Hisky Medical Technology Co Ltd
Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Fibrosis, HIV/AIDS
05/25
01/27
NCT05597566: Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression

Recruiting
N/A
72
RoW
modified electroconvulsive therapy
Qinge Zhang
Major Depression Disorder
10/22
12/22
WANG, GANG
NCT05861063: The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Recruiting
4
105
RoW
Fractional CO2 laser, paronosetron hydrochloride and lidocaine cream, Dezocine
Xijing Hospital
Acne Atrophica
12/23
12/24
NCT06355180: Esketamine Treatment for Depressive Episodes With Suicidal Ideation in Mood Disorders

Not yet recruiting
4
340
NA
Subanesthetic dose intravenous esketamine, esketamine, Modified electroconvulsive therapy, MECT
Capital Medical University, Wuhu Fourth People's Hospital, The Second People's Hospital of Dali Bai Autonomous Prefecture, Inner Mongolia Autonomous Region Mental Health Center, Beijing Chaoyang District Third Hospital, Beijing Daxing District Xinkang Hospital, Capital's Funds for Health Improvement and Research
Mood Disorders, Suicidal Ideation, Depressive Episode
12/26
12/26
NCT04532229: Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Recruiting
3
48
RoW
Nimotuzumab+CRT(concurrent IMRT and TMZ), h-R3
Biotech Pharmaceutical Co., Ltd.
Diffuse Intrinsic Pontine Glioma
10/23
12/23
NCT05862337: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Recruiting
3
480
RoW
Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatocellular Carcinoma
08/24
12/26
NCT05772104: Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Recruiting
3
495
RoW
Shugan Jieyu Capsules, Shugan Jieyu Capsules Placebo
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Generalized Anxiety Disorder
02/25
06/25
NCT05093855: Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Completed
2
41
RoW
BDB-001 Injection
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Hidradenitis Suppurativa
08/23
08/23
NCT06259526: A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Recruiting
2
260
RoW
Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule
Tasly Pharmaceutical Group Co., Ltd
Depression
04/25
04/25
NCT04388982: the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Recruiting
1/2
9
RoW
low dosage MSCs-Exos administrated for nasal drip, mild dosage MSCs-Exos administrated for nasal drip, high dosage MSCs-Exos administrated for nasal drip
Ruijin Hospital, Cellular Biomedicine Group Ltd.
Alzheimer Disease
08/21
08/22
NCT05103423: Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Completed
1/2
50
RoW
BDB-001 Injection, Placebo
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Hidradenitis Suppurativa
07/23
07/23
XYFY2021-KL184-01, NCT05211557: Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Recruiting
1/2
15
RoW
fhB7H3.CAR-Ts
The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech (Jiangsu) Co. Ltd
Ovarian Cancer
08/23
08/26
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting
1/2
380
RoW
PM8002
Biotheus Inc.
Malignant Neoplasm
11/25
11/25
NCT05323201: Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Recruiting
1/2
15
RoW
fhB7H3.CAR-Ts, B7H3 targeting chimeric antigen receptor T cells, Fludarabine, FLUDARA, Cyclophosphamide, Cytoxan
The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech Co. Ltd
Hepatocellular Carcinoma
02/24
02/27
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies

Recruiting
1/2
1300
Canada, US, RoW
SKB264
Klus Pharma Inc.
Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer
08/25
07/26
NCT05196971: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

Completed
1
12
RoW
HS-10345 84mg, HS-10345, Placebo, HS-10345 Placebo
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Treatment Resistant Depressive Disorder
04/22
10/22
NCT06393803: Phase 1 Study of KH607 Tablets

Recruiting
1
88
RoW
2mg KH607 tablets, 5mg KH607 tablets, 10mg KH607 tablets, 20mg KH607 tablets, 30mg KH607 tablets, 40mg KH607 tablets, 50mg KH607 tablets, 60mg KH607 tablets
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Healthy
10/24
10/24
NCT06105151: Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Recruiting
1
78
RoW
VV119(SAD), VV119 Placebo(SAD), VV119(FE)
Vigonvita Life Sciences
Schizophrenia
12/25
12/25
NCT06674694: The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

Recruiting
1
56
RoW
Brexpiprazole long-acting injection
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Schizophrenia Disorders
06/25
06/25
NCT06504290: Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

Recruiting
1
32
RoW
VV119 Placebo (in healthy adult subjects), VV119 (in healthy adult subjects), VV119(in adult patients with schizophrenia), VV119 Placebo (in adult patients with schizophrenia)
Vigonvita Life Sciences
Schizophrenia
07/25
07/25
NCT06556966: A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects

Not yet recruiting
1
66
NA
LY03020, LPM787000048 Maleate sustained-release tablet, Placebo, Placebo of LPM787000048 Maleate sustained-release tablet
Luye Pharma Group Ltd.
Schizophrenia, Alzheimer's Disease Psychosis
05/25
08/25
MIMI, NCT06534658: Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

Recruiting
N/A
1000
RoW
Ruijin Hospital
Alzheimer Disease, Image
07/29
08/29
NCT06552975: Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness

Recruiting
N/A
900
RoW
Infection
Qilu Hospital of Shandong University
Acute Febrile Illness
12/24
08/25
NCT06116162: Comparison of SVF-gel Filling and CO2 Fractional Laser on Atrophic Acne Scar Treatment

Completed
N/A
18
RoW
SVF-gel Filling and CO2 fractional laser
Xijing Hospital
Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling, CO2 Fractional Laser Treatment by Using Acupulse Device
07/22
01/23
NCT05961605: COVID-19 Associated With Psoriasis

Recruiting
N/A
2500
RoW
Gang Wang, MD
Psoriasis Patients, COVID-19
05/23
07/23
NCT05228483: Carbon Dioxide(CO2)Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus

Recruiting
N/A
134
RoW
CO2 fractional laser, 5-aminolevulinic acid (5-ALA) with red light illumination, Mometasone furoate (MMF) 0.1% ointment
Xijing Hospital
Vulva Lichen Sclerosus
11/23
06/24
NCT05827991: A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia

Recruiting
N/A
75
RoW
1565nm Non-ablative Fractional Laser, 5% minoxidil external use, 1565nm Non-ablative Fractional Laser combined with 5% minoxidil
Xijing Hospital
Androgenic Alopecia
12/23
12/23
BP, NCT06213909: Retrospective Study of the Effects of Sub-pathologic Phenotypes of on Clinical Management and Prognosis

Recruiting
N/A
318
RoW
This is a retrospective analysis of health data from inpatient record, no intervention was designed
Xijing Hospital
Bullous Pemphigoid
06/24
06/24
NCT05827913: Efficacy and Safety of Polylevolactic Acid Injection Combined With 1565nm Non-ablative Fractional Laser in the Treatment of Striae Distensae

Recruiting
N/A
30
RoW
Polylevolactic Acid Injection, 1565nm Non-ablative Fractional Laser, Polylevolactic Acid Injection combined with 1565nm Non-ablative Fractional Laser
Xijing Hospital
Striae Distensae
03/24
03/24
NCT06325527: Cognitive Impairment Cohort Study of the Elderly Population in YuGarden

Not yet recruiting
N/A
1872
RoW
Ruijin Hospital
Alzheimer Disease, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment
04/31
06/31
NCT06692361: Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients with Major Depressive Disorder

Recruiting
N/A
214
RoW
FMT capsule, microbiota capsule, FMT, Escitalopram (Lexapro), Escitalopram, Corn Starch capsules, Corn starch
Gang Wang, Shandong Daizhuang Hospital, Tianjin Anding Hospital, The First Affiliated Hospital, Zhejiang University, The First Hospital of Hebei Medical University, West China Hospital Affiliated with Sichuan University, Wuhu Fourth People's Hospital
Major Depressive Disorder (MDD), Depression - Major Depressive Disorder
06/26
12/26
SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting
N/A
1000
RoW
benralizumab
AstraZeneca
Chronic Obstructive Pulmonary Disease
01/26
01/26
COAST, NCT03653156: China Cognition and Aging Study

Recruiting
N/A
100000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia
01/38
01/38
CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting
N/A
40000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Alzheimer Disease, Familial Alzheimer Disease (FAD)
01/38
01/38
NCT05201521: Chinese FMDs Registry

Not yet recruiting
N/A
100
RoW
Ruijin Hospital
Functional Movement Disorders
08/23
01/24
SHARAD, NCT05597410: Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Recruiting
N/A
3418
RoW
Ruijin Hospital
Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment, Neurocognitive Disorders
03/29
03/30
SheMountain, NCT05667935: Cognitive Impairment Cohort Study of the Elderly Population in

Not yet recruiting
N/A
2000
RoW
Ruijin Hospital
Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment
12/30
01/31
Wang, Xiao Min
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Recruiting
4
5000
RoW
Peginterferon Alfa-2B, Nucleoside Analogs
Third Affiliated Hospital, Sun Yat-Sen University
Hepatitis B, Chronic
12/26
11/29
NCT06842199: Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Not yet recruiting
3
360
RoW
ICP-488 Tablets, ICP-488 Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Plaque Psoriasis Patients
05/26
02/27
TSL-TCM-QZKL-Ⅲ, NCT06068478: A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

Recruiting
3
472
RoW
Qingzhu Granules, Qingzhu Granules Placebo
Tasly Pharmaceutical Group Co., Ltd
Gouty Arthritis
10/25
10/25
NCT05924373: Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients

Recruiting
2
204
RoW
Human Dental Fulp Stem Cells, Initial periodontal therapy
Peking University Third Hospital, Capital Medical University
Periodontitis
03/25
09/26
NCT05653310: Tradipitant for Functional Dyspepsia

Enrolling by invitation
2
60
US
Tradipitant, Placebo
Xiao Jing (Iris) Wang, Mayo Clinic
Functional Dyspepsia
12/25
12/25
NCT04983225: The Safety and Tolerability of Initial Periodontal Therapy Combined With Human Dental Pulp Stem Cell Injection in the Treatment of Chronic Periodontitis

Active, not recruiting
1
36
RoW
Human Dental Pulp Stem Cells, Initial periodontal therapy, Saline solution
Peking University Third Hospital, Capital Medical University
Periodontitis
07/24
08/24
NCT05954598: Effect of Probiotic vs Placebo on Cognition Outcomes in Patients With Bipolar Disorder

Recruiting
N/A
100
RoW
probiotic
First Affiliated Hospital of Zhejiang University
Bipolar Disorder
05/22
12/24
CAD-MAP, NCT06202300: Myocardial and Arterial Phenotype of Coronary Artery Disease

Recruiting
N/A
5000
RoW
Inflammation burden
Beijing Anzhen Hospital
Coronary Artery Disease
06/24
06/24
NCT06358014: Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen

Recruiting
N/A
40
RoW
Fematon (estradiol/estradiol-norethindrone acetate combination tablet package)+SSRIs, SSRIs
Xiao Wang
Postmenopausal Depression, Estrogen
12/24
12/24
NCT05572606: Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol

Active, not recruiting
N/A
25
US
Hypnotherapy
Mayo Clinic
Bloating
12/23
10/25
GAVE, NCT06306963: Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Recruiting
N/A
30
US
Gastric Emptying Breath Test, Gastric motor function testing
Mayo Clinic, Cairn Diagnostics
Gastric Antral Vascular Ectasia, Cirrhosis, Chronic Kidney Disease
03/26
09/26
NCT06846359: Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions

Recruiting
N/A
100
US
Hypnotherapy, Educational module
Mayo Clinic
GI Symptoms
02/26
02/27
NCT06074770: Study on Dietary Intake Levels of Iodine for 3-6 Years Old Pre-school Children

Recruiting
N/A
2650
RoW
no intervention
Chen Wen, Shandong Institute for Endemic Disease Control and Research
Nutritional Requirements
12/26
12/26
Zhang, Qinge
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Recruiting
4
1312
RoW
GV-971, Placebo
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer's Disease
06/29
12/29
TRAILRUNNER-ALZ 3, NCT06653153: A Study of Remternetug (LY3372993) in Early Alzheimer's Disease

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Remternetug, LY3372993, Placebo
Eli Lilly and Company
Alzheimer's Disease
04/29
10/30
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
04/27
04/27
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Recruiting
2a
60
RoW
50561 high dose, 50561 low dose, Placebo
Beijing Joekai Biotechnology LLC
Alzheimer's Disease
05/24
06/24
NCT05588102: Electronic Training of Elderly Depression With Cognitive Impairment

Completed
N/A
128
RoW
Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram), Electronic cognitive training
Capital Medical University
Geriatric Depression, Cognitive Impairment
05/23
08/23

Download Options